journal

P & T: a Peer-reviewed Journal for Formulary Management

journal
https://read.qxmd.com/read/31485153/looking-for-trouble-identifying-and-treating-hypotension
#1
(no author information available yet)
No abstract text is available yet for this article.
September 2019: P & T: a Peer-reviewed Journal for Formulary Management
https://read.qxmd.com/read/31485152/research-briefs
#2
(no author information available yet)
No abstract text is available yet for this article.
September 2019: P & T: a Peer-reviewed Journal for Formulary Management
https://read.qxmd.com/read/31485151/the-impact-of-self-monitoring-blood-glucose-adherence-on-glycemic-goal-attainment-in-an-indigent-population-with-pharmacy-assistance
#3
Whitley M Yi, Emily M Van Wieren Jones, B Kyle Hansen, Jay Vora
Self-monitoring of bood glucose alone is not a good predictor of HbA1c goal attainment. Health plans might benefit from formulary restrictions to provide more cost-effective care, without negatively impacting glycemic control. And by using targeted inteventions, healthcare providers could help maximize SMBG's clinical benefit for patients who receive test strips. Self-monitoring of blood glucose (SMBG) can be an important tool in diabetes treatment, both for patient self-management and for guiding clinicians regarding medication adjustments...
September 2019: P & T: a Peer-reviewed Journal for Formulary Management
https://read.qxmd.com/read/31485150/continuous-glucose-monitoring-a-review-of-available-systems
#4
Vienica D Funtanilla, PharmD Candidate, Tina Caliendo, Olga Hilas
Continuous glucose monitoring offers patients with diabetes a new option for monitoring their glucose levels on a regular basis, without the need for perpetual finger-sticks and myriad supplies.
September 2019: P & T: a Peer-reviewed Journal for Formulary Management
https://read.qxmd.com/read/31485149/bleeding-and-elevated-inr-secondary-to-concomitant-tramadol-and-warfarin-administration
#5
Keith T Veltri, William A Olsufka
The exact mechanism of a tramadol-warfarin interaction has not been fully determined. The authors present a case study that illustrates the risks.
September 2019: P & T: a Peer-reviewed Journal for Formulary Management
https://read.qxmd.com/read/31485148/antibiotic-breakpoints-how-redefining-susceptibility-preserves-efficacy-and-improves-patient-care
#6
Mark Redell, Glenn Tillotson
Carbapenems are a primary treatment for infections from multidrug-resistant bacterial pathogens. To maintain their efficacy and control the emergence of further resistance, breakpoints that correspond to recommended doses with appropriate PK/PD target attainment are paramount.
September 2019: P & T: a Peer-reviewed Journal for Formulary Management
https://read.qxmd.com/read/31485147/democratic-presidential-candidates-lead-attack-on-drug-prices-health-insurance-expansions-tougher-on-drugs-than-dems-bill-in-house
#7
Stephen Barlas
House Democrats have been loudly proclaiming their intention to pass legislation that would rein in drug-price increases. But when it comes to actually passing significant bills, reality has not matched rhetoric.
September 2019: P & T: a Peer-reviewed Journal for Formulary Management
https://read.qxmd.com/read/31485146/evaluation-of-warfarin-patients-with-low-time-in-therapeutic-range-ttr-for-transition-to-non-vitamin-k-oral-anticoagulant-noac-therapy
#8
Lindsey M Fovel, Christopher D Miller, Robert W Seabury, Luke A Probst, Lara Horvath
No abstract text is available yet for this article.
September 2019: P & T: a Peer-reviewed Journal for Formulary Management
https://read.qxmd.com/read/31485145/andexanet-alfa-preferred-treatment-or-therapeutic-option
#9
Curtis A Blow, Luke A Probst, Christopher D Miller, Robert W Seabury
No abstract text is available yet for this article.
September 2019: P & T: a Peer-reviewed Journal for Formulary Management
https://read.qxmd.com/read/31485144/andexanet-alfa-andexxa-%C3%A2-for-the-reversal-of-direct-oral-anticoagulants
#10
Jayed H Momin, PharmD Candidate, Gregory J Hughes
Andexanet alfa (Andexxa® ) for the reversal of direct oral anticoagulants.
September 2019: P & T: a Peer-reviewed Journal for Formulary Management
https://read.qxmd.com/read/31485143/pharmaceutical-approval-update
#11
Mary Choy
Alpelisib (Piqray) for HR-positive/HER2-negative, PIK3CA-mutated, advanced/ metastatic breast cancer; polatuzumab vedotin-piiq (Polivy) for diffuse large B-cell lymphoma; and eculizumab (Soliris) for neuromyelitis optica spectrum disorder.
September 2019: P & T: a Peer-reviewed Journal for Formulary Management
https://read.qxmd.com/read/31485142/drug-and-device-news
#12
(no author information available yet)
Approvals, new indications and formulations, and safety issues.
September 2019: P & T: a Peer-reviewed Journal for Formulary Management
https://read.qxmd.com/read/31485141/bipartisan-drug-patent-bills-ready-for-senate-vote-efforts-directed-at-speeding-up-introduction-of-generics
#13
Stephen Barlas
The legal tactics that drug manufacturers use to extend drug patents may be the biggest impediment to lowering drug prices and to Congress acting on pricing. Until now, that is.
September 2019: P & T: a Peer-reviewed Journal for Formulary Management
https://read.qxmd.com/read/31485140/hardwiring-safety-into-the-computer-system-one-hospital-s-actions-to-provide-technology-support-for-u-500-insulin
#14
Matthew Grissinger
We present technology enhancements that support the safe use of U-500 insulin.
September 2019: P & T: a Peer-reviewed Journal for Formulary Management
https://read.qxmd.com/read/31447540/research-briefs
#15
(no author information available yet)
No abstract text is available yet for this article.
August 2019: P & T: a Peer-reviewed Journal for Formulary Management
https://read.qxmd.com/read/31447539/employer-provider-interface-council-epic-2019-managing-health-benefits-in-the-era-of-change
#16
Michelle N Segovia
No abstract text is available yet for this article.
August 2019: P & T: a Peer-reviewed Journal for Formulary Management
https://read.qxmd.com/read/31447538/-it-starts-with-one-reflections-on-bio-2019
#17
John Otrompke
No abstract text is available yet for this article.
August 2019: P & T: a Peer-reviewed Journal for Formulary Management
https://read.qxmd.com/read/31447537/american-society-of-clinical-oncology-2019
#18
Walter Alexander
No abstract text is available yet for this article.
August 2019: P & T: a Peer-reviewed Journal for Formulary Management
https://read.qxmd.com/read/31447536/outcomes-of-inpatient-administration-of-restricted-antineoplastic-medications-at-a-large-academic-medical-institution
#19
Kimberly M Lau, Katrina Derry, Ashley Dalton, Janine Martino
Background: Restricting oncology and hematology medications to outpatient infusion centers may be considered when infrequent administration is required, a low risk of serious adverse effects exists, or when prompt amelioration of a condition is not expected. At the University of California, San Diego (UCSD), we created a new formulary status for medications designated "formulary, outpatient-restricted use only." This designation could optimize payer reimbursement, as well as improve patient comfort, by negating the need for inpatient admission...
August 2019: P & T: a Peer-reviewed Journal for Formulary Management
https://read.qxmd.com/read/31447535/savings-on-high-cost-drugs-such-as-atypical-long-acting-injectable-antipsychotics-switching-to-billing-under-the-pharmacy-benefit-in-outpatient-settings
#20
Aliaksandr Budovich, Maria M Claudio-Saez, Jason Hershberger
Objective: Access to health care can be improved by controlling and optimizing expenditures, specifically the high-cost drugs such as atypical long-acting injectable (LAI) antipsychotics. This type of LAI is usually covered under the medical benefit and/or pharmacy benefit. We sought to compare financial outcomes of the medical benefit billing option with the pharmacy benefit billing option for atypical LAIs in an adult outpatient psychiatric clinic and to determine insurance companies' reasons for nonpayment when the medical benefit billing model was utilized...
August 2019: P & T: a Peer-reviewed Journal for Formulary Management
journal
journal
30579
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"